The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 17, 2024

Filed:

Feb. 08, 2019
Applicant:

The Macfarlane Burnet Institute for Medical Research and Public Health Ltd, Melbourne, AU;

Inventors:

David Andrew Anderson, Melbourne, AU;

Mary Louise Garcia, Melbourne, AU;

Nadine Carmel Barnes, Melbourne, AU;

Khayriyyah Mohd Hanafiah, Melbourne, AU;

Alan Lee Landay, Melbourne, AU;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 14/705 (2006.01); G01N 33/569 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
C07K 14/70503 (2013.01); G01N 33/56983 (2013.01); G01N 33/6854 (2013.01); C07K 2319/00 (2013.01); G01N 2333/08 (2013.01); G01N 2333/10 (2013.01); G01N 2333/16 (2013.01); G01N 2333/70535 (2013.01); G01N 2469/20 (2013.01); G01N 2800/06 (2013.01);
Abstract

The specification describes an antibody capture process comprising (i) obtaining a biological sample comprising antibodies, (ii) contacting the biological sample with recombinant pIgR or a dIgA-binding variant, wherein the pIgR or variant binds dIgA and forms a pIgR-dIgA complex. The process may further comprise (iii) directly or indirectly assessing the level of the pIgR-dIgA complex or the level of a complex between pIgR-dIgA and an antigen of interest. There is also an antibody capture process for determining gut wall integrity in a test subject, wherein the level or ratio of SIgA to dIgA is compared to a corresponding level or ratio from a control subject. The specification provides kits embodying the process and recombinant pIgR when used for, or for use, in capturing or detecting dIgA and/or IgM.


Find Patent Forward Citations

Loading…